Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019
- PMID: 33769247
- PMCID: PMC7995557
- DOI: 10.2807/1560-7917.ES.2021.26.12.2000244
Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019
Erratum in
-
Correction for Euro Surveill. 2021;26(12).Euro Surveill. 2022 Jan;27(2):220113c. doi: 10.2807/1560-7917.ES.2022.27.2.220113c. Euro Surveill. 2022. PMID: 35027103 Free PMC article. No abstract available.
Abstract
In March 2019, a pertussis outbreak occurred in children in a junior school (7-11 years) in England who had been offered pertussis-containing booster vaccine at 40 months of age. In a case-control investigation, we assessed the extent of transmission and any difference in protection afforded to those who had previously received a booster 3- or 5-component acellular pertussis vaccine (aP). We took oral fluid specimens from the students to determine IgG antibodies against pertussis toxin (anti-PT). Parents of students attending the school were sent a questionnaire on pertussis symptoms and vaccination status was retrieved from general practitioner records for all students. Of 381 students, 134 (35.2%) were classified as pertussis cases, 133 by demonstration of significant anti-PT IgG titres and one clinically. There was no significant difference in the risk of pertussis between students receiving 3-component (33.7%) or 5-component (32.3%) aP boosters. However, pertussis infection differed significantly in school year 4, with 22.9%, 50.0%, 23.7% and 38.1% pertussis cases in years 3, 4, 5 and 6, respectively. The proportion of students with incomplete vaccinations recorded was higher than the proportion of those not covered according to the national reported coverage, possibly contributing to sustained transmission within the school.
Keywords: 3-component; 5-component; acellular vaccine; outbreak; pertussis.
Conflict of interest statement
Figures
Similar articles
-
Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.Vaccine. 2018 Jan 4;36(2):220-226. doi: 10.1016/j.vaccine.2017.11.066. Epub 2017 Dec 1. Vaccine. 2018. PMID: 29199041
-
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.Pediatrics. 2001 Nov;108(5):E81. doi: 10.1542/peds.108.5.e81. Pediatrics. 2001. PMID: 11694665 Clinical Trial.
-
Retrospective cohort study investigating extent of pertussis transmission during a boarding school outbreak, England, December 2017 to June 2018.Euro Surveill. 2021 Jul;26(26):1900736. doi: 10.2807/1560-7917.ES.2021.26.26.1900736. Euro Surveill. 2021. PMID: 34212843 Free PMC article.
-
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000. Drugs. 2012. PMID: 22931522 Review.
-
Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.Vaccine. 2013 Oct 25;31(45):5178-91. doi: 10.1016/j.vaccine.2013.08.034. Epub 2013 Aug 28. Vaccine. 2013. PMID: 23994021 Review.
Cited by
-
Comparing the pertussis antibody levels of healthy children immunized with four doses of DTap-IPV/Hib (Pentaxim) combination vaccine and DTaP vaccine in Quzhou, China.Front Immunol. 2023 Jan 6;13:1055677. doi: 10.3389/fimmu.2022.1055677. eCollection 2022. Front Immunol. 2023. PMID: 36685526 Free PMC article.
-
The association between vaccine hesitancy and pertussis: a systematic review and meta-analysis.Ital J Pediatr. 2023 Jul 13;49(1):81. doi: 10.1186/s13052-023-01495-8. Ital J Pediatr. 2023. PMID: 37443026 Free PMC article.
-
Impact of the COVID-19 pandemic on Bordetella pertussis infections in England.BMC Public Health. 2022 Feb 28;22(1):405. doi: 10.1186/s12889-022-12830-9. BMC Public Health. 2022. PMID: 35220973 Free PMC article.
-
The Present and Future Aspects of Life-Long Pertussis Prevention: Narrative Review with Regional Perspectives for Türkiye.Infect Dis Ther. 2023 Nov;12(11):2495-2512. doi: 10.1007/s40121-023-00876-0. Epub 2023 Oct 10. Infect Dis Ther. 2023. PMID: 37815753 Free PMC article. Review.
-
Epidemiological investigation of a pertussis outbreak among schoolchildren in Burkina Faso, 2019.BMC Res Notes. 2025 Feb 10;18(1):60. doi: 10.1186/s13104-025-07129-y. BMC Res Notes. 2025. PMID: 39930513 Free PMC article.
References
-
- Tan TQ. Pertussis and pertussis syndrome. In: Domachowske J, editor. introduction to clinical infectious diseases: a problem-based approach. Cham: Springer International Publishing; 2019. p. 67-73.
-
- Hendrick L, Ward M. P365 Pertussis vaccination: Should we be doing something different? Arch Dis Child. 2019;104(Suppl 3):A302-3. 10.1136/archdischild-2019-epa.711 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical